In a 10,000-patient in silico trial, alternating temozolomide cycles with CAR-T cell injections produced the longest median survival for modeled malignant gliomas.
Stupp , author W
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
math.DS 1years
2025 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
A mathematical model of CAR-T cell therapy in combination with chemotherapy for malignant gliomas
In a 10,000-patient in silico trial, alternating temozolomide cycles with CAR-T cell injections produced the longest median survival for modeled malignant gliomas.